Skip to main content
. 2021 Aug 11;10(4):1949–1988. doi: 10.1007/s40121-021-00499-3

Fig. 2.

Fig. 2

Meningococcal outbreaks/epidemics in the Americas 1997–2020. 4CMenB, 4-component meningococcal serogroup B vaccine; CV, conjugate vaccine; FDA, Food and Drug Administration; m, months of age; MenB-fHbp, meningococcal serogroup B vaccine containing Factor H binding protein; Men(A/C/W/Y), meningococcal vaccine containing one serogroup or combinations of serogroups A, C, W and Y; n, number of cases; PS, polysaccharide vaccine; y, years of age